Association Between Mental Health Disorders, Problem Drug Use, and Regular Prescription Opioid Use | Psychiatry and Behavioral Health | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
Gureje  OVon Korff  MSimon  GEGater  R Persistent pain and well-being: a World Health Organization Study in Primary Care.  JAMA 1998;280147- 151[published correction appears in JAMA. 1998;280:1142]PubMedGoogle ScholarCrossref
2.
Caudill-Slosberg  MASchwartz  LMWoloshin  S Office visits and analgesic prescriptions for musculoskeletal pain in US.  Pain 2004;109514- 519PubMedGoogle ScholarCrossref
3.
Portenoy  RK Appropriate use of opioids for persistent non-cancer pain.  Lancet 2004;364739- 740PubMedGoogle ScholarCrossref
4.
Von Korff  MDeyo  RA Potent opioids for chronic musculoskeletal pain: flying blind?  Pain 2004;109207- 209PubMedGoogle ScholarCrossref
5.
Breckenridge  JClark  JD Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain.  J Pain 2003;4344- 350PubMedGoogle ScholarCrossref
6.
Reid  MCEngles-Horton  LLWeber  MBKerns  RDRogers  ELO'Connor  PG Use of opioid medications for chronic noncancer pain syndromes in primary care.  J Gen Intern Med 2002;17173- 179PubMedGoogle ScholarCrossref
7.
Turk  DCOkifuji  A What factors affect physicians' decisions to prescribe opioids for chronic noncancer pain patients?  Clin J Pain 1997;13330- 336PubMedGoogle ScholarCrossref
8.
Sullivan  MDEdlund  MJSteffick  DUnutzer  J Regular use of prescribed opioids: association with common psychiatric disorders.  Pain 2005;11995- 103PubMedGoogle ScholarCrossref
9.
Sturm  RGresenz  CSherbourne  C  et al.  The design of Healthcare for Communities.  Inquiry 1999;36221- 233PubMedGoogle Scholar
10.
Kemper  PBlumenthal  DCorrigan  JM  et al.  The design of the Community Tracking Study.  Inquiry 1996;33195- 206PubMedGoogle Scholar
11.
Andersen  RM Revisiting the behavioral model and access to medical care: does it matter?  J Health Soc Behav 1995;361- 10PubMedGoogle ScholarCrossref
12.
Ware  J  JrKosinski  MKeller  SD A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity.  Med Care 1996;34220- 233PubMedGoogle ScholarCrossref
13.
Aalto-Setala  THaarasilta  LMarttunen  M  et al.  Major depression among young adults: CIDI-SF versus SCAN diagnoses.  Psychol Med 2002;321309- 1314PubMedGoogle ScholarCrossref
14.
 Composite International Diagnostic Interview (CIDI) Version 2.1.  Geneva, Switzerland World Health Organization1995;
15.
American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition.  Washington, DC American Psychiatric Association1987;
16.
 The Alcohol Use Disorders Identification Test (AUDIT): Guidelines for Use in Primary Health Care.  Geneva, Switzerland World Health Organization1992;
17.
Sees  KLClark  HW Opioid use in the treatment of chronic pain: assessment of addiction.  J Pain Symptom Manage 1993;8257- 264PubMedGoogle ScholarCrossref
18.
Miotto  KCompton  PLing  WConolly  M Diagnosing addictive disease in chronic pain patients.  Psychosomatics 1996;37223- 235PubMedGoogle ScholarCrossref
19.
 Language Manual SUDAAN, Release 9.0.  Research Triangle Park, NC Research Triangle Institute2004;
20.
Katon  WSullivan  MWalker  E Medical symptoms without identified pathology.  Ann Intern Med 2001;134917- 925PubMedGoogle ScholarCrossref
21.
Wasan  ADDavar  GJamison  R The association between negative affect and opioid analgesia in patients with discogenic low back pain.  Pain 2005;117450- 461PubMedGoogle ScholarCrossref
22.
Harris  KMEdlund  MJ Self-medication of mental health problems: new evidence from a national survey.  Health Serv Res 2005;40117- 134PubMedGoogle ScholarCrossref
23.
Jackson  S Melancholia and Depression.  New Haven, Conn Yale University Press1986;
24.
Narayanan  SLam  HChristian  L  et al.  Endogenous opioids mediate basal hedonic tone independent of dopamine D-1 or D-2 receptor activation.  Neuroscience 2004;124241- 246PubMedGoogle ScholarCrossref
25.
Bodkin  JAZornberg  GLLukas  SECole  JO Buprenorphine treatment of refractory depression.  J Clin Psychopharmacol 1995;1549- 57PubMedGoogle ScholarCrossref
26.
Koran  LMAboujaoude  EBullock  KDFranz  BGamel  NElliott  M Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder.  J Clin Psychiatry 2005;66353- 359PubMedGoogle ScholarCrossref
27.
Mills  KLTeesson  MRoss  JDarke  SShanahan  M The costs and outcomes of treatment for opioid dependence associated with posttraumatic stress disorder.  Psychiatr Serv 2005;56940- 945PubMedGoogle ScholarCrossref
28.
Dulit  RAFyer  MRHaas  GLSullivan  TFrances  AJ Substance use in borderline personality disorder.  Am J Psychiatry 1990;1471002- 1007PubMedGoogle Scholar
29.
Saper  JR Borderline personality, opioids, and naltrexone [letter].  Headache 2000;40765PubMedGoogle ScholarCrossref
30.
Sansone  RAHawkins  R Fibromyalgia, borderline personality, and opioid prescription.  Gen Hosp Psychiatry 2004;26415- 416PubMedGoogle ScholarCrossref
31.
Bohus  MJLandwehrmeyer  GBStiglmayr  CELimberger  MFBohme  RSchmahl  CG Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder.  J Clin Psychiatry 1999;60598- 603PubMedGoogle ScholarCrossref
32.
Kalso  EEdwards  JEMoore  RAMcQuay  HJ Opioids in chronic non-cancer pain: systematic review of efficacy and safety.  Pain 2004;112372- 380PubMedGoogle ScholarCrossref
33.
Joint Commission on Accreditation of Healthcare Organizations, ed, Current understanding of assessment, management and treatments. Improving the Quality of Pain Management Through Measurement and Action.  Reston, Va National Pharmaceutical Council1991;
34.
 Recommendations for the Appropriate Use of Opioids for Persistent Non-Cancer Pain. 2004 London, England Pain Society2004;
35.
 The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society.  Clin J Pain 1997;136- 8PubMedGoogle ScholarCrossref
36.
Drug Enforcement Administration, A joint statement from 21 health organizations and the Drug Enforcement Administration: promoting pain relief and preventing abuse of pain medications: a critical balancing act [guideline].  J Pain Symptom Manage 2002;24147PubMedGoogle Scholar
37.
Ballantyne  JCMao  J Opioid therapy for chronic pain.  N Engl J Med 2003;3491943- 1953PubMedGoogle ScholarCrossref
38.
Chodosh  JSolomon  DHRoth  CP  et al.  The quality of medical care provided to vulnerable older patients with chronic pain.  J Am Geriatr Soc 2004;52756- 761PubMedGoogle ScholarCrossref
39.
Lin  EHKaton  WVon Korff  M  et al.  Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial.  JAMA 2003;2902428- 2429PubMedGoogle ScholarCrossref
40.
Kennedy  BPKawachi  IGlass  RProthrow-Stith  D Income distribution, socioeconomic status, and self rated health in the United States: multilevel analysis.  BMJ 1998;317917- 921PubMedGoogle ScholarCrossref
Original Investigation
October 23, 2006

Association Between Mental Health Disorders, Problem Drug Use, and Regular Prescription Opioid Use

Author Affiliations

Author Affiliations: Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (Drs Sullivan and Unützer); Department of Psychiatry, University of Arkansas for Medical Sciences, Little Rock (Dr Edlund); Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles (Ms Zhang and Dr Wells).

Arch Intern Med. 2006;166(19):2087-2093. doi:10.1001/archinte.166.19.2087
Abstract

Background  Use of opioids for chronic noncancer pain is increasing, but standards of care for this practice are poorly defined. Psychiatric disorders are associated with increased physical symptoms such as pain and may be associated with opioid use, but no prospective population-based studies have addressed this issue.

Methods  Analysis of longitudinal data from 6439 participants in the 1998 and 2001 waves of Healthcare for Communities, a nationally representative telephone community survey.

Results  Two hundred thirty-seven subjects (3.6%) reported regular prescription opioid use in 2001. In unadjusted logistic regression models, respondents with a common mental health disorder in 1998 (1165 [12.6%]; major depression, dysthymia, generalized anxiety disorder, or panic disorder) were more likely to report opioid use in 2001 than those without any of these disorders (odds ratio [OR], 4.43; 95% confidence interval [CI], 3.64-5.38; P<.001). Risk was increased for initiation (OR, 3.26; 95% CI, 2.44-4.34; P<.001) and continuation (OR, 2.30; 95% CI, 1.02-5.17; P = .04) of opioids. Respondents reporting problem drug use (136 [2.0%]; OR, 3.57; 95% CI, 2.32-5.50; P<.001) but not problem alcohol use (401 [6.5%]; OR, 0.73; 95% CI, 0.43-1.24; P = .25) reported higher rates of prescribed opioid use than those without problem use. In multivariate logistic regression models controlling for 1998 demographic and clinical variables, common mental health disorder (OR, 1.96; 95% CI, 1.47-2.62; P<.001) and problem drug use (OR, 2.98; 95% CI, 1.68-5.30; P<.001) remained significant predictors of opioid use in 2001.

Conclusions  Common mental health disorders and problem drug use are associated with initiation and use of prescribed opioids in the general population. Attention to psychiatric disorders is important when considering opioid therapy.

×